CompletedNCT02456896
Oxcarbazepine and BDNF Blood Levels in Bipolarity
About this title
Read the official source — NCT02456896Medication studyAges 18–45India
Understand this study
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- BhubaneswarSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJune 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- India
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT02456896
- Official title
Show the full official title
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bhubaneswar
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Oxcarbazepine.
Who was this study for?
Listed age limits: 18 years to 45 years.
